Manufacturer record
Healers Lab Unit II: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by Healers Lab Unit II (Himachal Pradesh) were declared Not of Standard Quality between November 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: OFB-506, Ofloxacin Tablets I.P. 400 mg (exp Feb 2026). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Dissolution test. Listed in the December 2025 alert.
Records by type
18 records linked to Healers Lab Unit II in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin Tablets I.P. 400 mg | Batch OFB-506Mfg Mar 2023 · Exp Feb 2026 | Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Dec 2025 |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | Batch CDA-583Mfg Mar 2025 · Exp Feb 2027 | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | Batch CDA-586Mfg Mar 2025 · Exp Feb 2027 | The sample does not comply as per I.P. 2022 with respect to the Test for "Assay" of Vitamin D3 and "Dissolution" for Calcium.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| Pantoprazole Tablets I.P.. | Batch PAA-528Mfg Apr 2025 · Exp Mar 2027 | sample does not comply as per I.P. 2022 with respect to the test for "Dissolution in buffer stage" For Pantoprazole.Dissolution | RDTL, GuwahatiCDSCO lab | Sep 2025 |
| Telmisartan Tablets IP 40mg | Batch TLL-507Mfg Jan 2025 · Exp Dec 2026 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | Batch TLL-505Mfg Jan 2025 · Exp Dec 2026 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | Batch TLL-505Mfg Jan 2025 · Exp Dec 2026 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | Batch TLL-504Mfg Jan 2025 · Exp Dec 2026 | Dissolution of TelmisartanDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Telmisartan Tablets IP 40 mg | Batch TLL-503Mfg Jan 2025 · Exp Dec 2026 | Dissolution of TelmisartanDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Ursodeoxycholic acid Tablets IP 300 mg | Batch UDS-501Mfg Aug 2024 · Exp Jul 2026 | The sample does not confirm to claim as per IP 2022 in respect to the Dissolution of Ursodiol (Ursodeoxycholic Acid)Dissolution | DTL Baddi Distt. SolanState lab | May 2025 |
| Pantoprazole Tablets I.P.. | Batch PAA-507Mfg Jun 2023 · Exp May 2025 | The sample Does not complies conforms to Manufacturer Specification with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Pantoprazole Tablets I.P.. | Batch PAA-507Mfg Jun 2023 · Exp May 2025 | The sample Does not complies conforms to Manufacturer Specification with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Levocetirizine Tablets IP | Batch LVU-515Mfg Jun 2023 · Exp May 2025 | Identification and Assay of Levocetirizine HydrochlorideAssay | RDTL ChandigarhCDSCO lab | Jan 2024 |
| Paracetamol Tablets IP 500 mg | Batch PRS-520Mfg Aug 2022 · Exp Jul 2025 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Nov 2023 |
| PANTOPRAZOLE TABLETS I.P. (40 mg) | Batch PAA-504Mfg Jan 2023 · Exp Dec 2024 | Dissolution in Acid Stage & DescriptionDissolution | RDTL GuwahatiState lab | Oct 2023 |
| Glimepiride Tablets IP 1 mg | Batch GPG-531Mfg Apr 2023 · Exp Mar 2025 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Oct 2023 |
| Glimepiride Tablets IP 1 mg | Batch GPU-511Mfg Sep 2021 · Exp Aug 2023 | Dissolution and Related SubstancesDissolution | RDTL ChandigarhCDSCO lab | Feb 2023 |
| Tolperisone Hydrochloride Tablets 150 mg | Batch TSB-501Mfg Dec 2021 · Exp Nov 2023 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.